Amazon.Com Inc (AMZN) 758.81 $AMZN ExxonMobil's 10

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 8:23 AM

Amazon.Com Inc (AMZN) 758.81 $AMZN

ExxonMobil's 10 Top-Valued Projects Chained to Sinking Prices of Commodities, LNG, an Industrial Info News Alert
Marketwired - 1 hr 13 mins ago
SUGAR LAND, TX--(Marketwired - Aug 1, 2016) - Researched by Industrial Info Resources (Sugar Land, Texas)--Friday morning witnessed an easily overlooked milestone in the recent economic recovery: Exxon Mobil Corporation (NYSE:XOM) (Irving, Texas) was surpassed in market value by Facebook (NASDAQ:FB) (Menlo Park, California) and Amazon.com (NASDAQ:AMZN) (Seattle, Washington), making it the last oil & gas company to leave the world's five most valuable companies, which are now inhabited entirely by tech firms. ExxonMobil may yet rebound, but investors have known for a long time that two major factors have been weighing it down: the oversupply of liquefied natural gas (LNG) in the global market, and persistently low commodity prices. Industrial Info is tracking about $140 billion in active projects involving ExxonMobil on five continents, more than 95% of which are in three industries: Oil & Gas Production, Oil & Gas Pipelines and Chemical Processing.
AMZN: 758.81 (+6.20), FB: 123.94 (-1.06), XOM: 88.95 (-1.25)

Global markets shrug off bleak US, Chinese data
By ELAINE KURTENBACH - AP - Mon Aug 01, 4:19AM CDT
BANGKOK (AP) — Global shares were mostly higher on Monday, as investors shrugged off disappointing growth data from the U.S. and lackluster but better-than-expected manufacturing figures for China.
AMZN: 758.81 (+6.20)

Asian markets shrug off bleak US data, Chinese shares drop
By ELAINE KURTENBACH - AP - Sun Jul 31, 11:49PM CDT
BANGKOK (AP) — Shares were higher Monday in Asia, as investors shrugged off disappointing growth data from the U.S. and lackluster but better-than-expected manufacturing figures for China.
AMZN: 758.81 (+6.20)

Zacks Friday Finish Line: Earnings Season Continues!
Ryan McQueeney - Zacks Investment Research - Fri Jul 29, 4:17PM CDT
On today's episode of the Zacks Friday Finish Line podcast the hosts talk about Oracle, Verizon and Yahoo, and earnings from Twitter, Amazon, Facebook, Apple, and Alphabet.
YHOO: 38.19 (-0.33), AMZN: 758.81 (+6.20), FB: 123.94 (-1.06), GOOGL: 791.34 (+25.50), N: 108.85 (+0.44), TWTR: 16.64 (+0.33), AAPL: 104.21 (-0.13), VZ: 55.41 (+0.55), ORCL: 41.04 (-0.15)

Business Highlights
By The Associated Press - AP - Fri Jul 29, 4:01PM CDT
___
FDX: 161.90 (+0.45), AMZN: 758.81 (+6.20), BUD: 129.44 (+3.52), MRK: 58.66 (+0.23), SNE: 33.41 (+2.73), BP: 34.40 (+0.41), CVX: 102.48 (+0.69), UPS: 108.10 (-0.63)

How the Dow Jones industrial average fared on Friday
AP - Fri Jul 29, 3:48PM CDT
NEW YORK (AP) — Stocks ended slightly higher on Friday, helped by better-than-expected quarterly results from Google's parent Alphabet and retailer Amazon and a modest recovery in oil prices.
AMZN: 758.81 (+6.20)

Exxon Mobil and Stericycle stumble; Alphabet and Newell jump
AP - Fri Jul 29, 3:46PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Friday:
CI: 128.96 (-7.03), AMZN: 758.81 (+6.20), EMN: 65.23 (-5.14), NWL: 52.46 (+3.07), EXPE: 116.65 (-2.62), SRCL: 90.27 (-15.66), GOOGL: 791.34 (+25.50), GOOG: 768.79 (+22.88)

Apple iMessage Will Bring Millions to Mobile Marketing
David Bartosiak - Zacks Investment Research - Fri Jul 29, 3:40PM CDT
Apple opening up iMessage to developers will pay off bigtime for marketing firms like Snaps
AMZN: 758.81 (+6.20), FB: 123.94 (-1.06), GOOGL: 791.34 (+25.50), MSFT: 56.68 (+0.47), AAPL: 104.21 (-0.13)

Internet Stocks Earnings Reports: FB vs. AMZN
Ryan McQueeney - Zacks Investment Research - Fri Jul 29, 3:38PM CDT
Both Facebook (FB) and Amazon (AMZN) impressed investors, but which company really stole the show this week?
AMZN: 758.81 (+6.20), FB: 123.94 (-1.06)

Markets Right Now: Stocks end mostly higher
AP - Fri Jul 29, 3:14PM CDT
NEW YORK (AP) — The latest on developments in global financial markets (all times local):
AMZN: 758.81 (+6.20), CVX: 102.48 (+0.69)

ETFs to Gain as Amazon Crushes Q2 Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 12:56PM CDT
Aside from witnessing strong growth in both earnings and revenues, Amazon easily outpaced our consensus estimates
FDIS: 32.00 (+0.05), AMZN: 758.81 (+6.20), XLY: 81.62 (+0.09), FDN: 77.52 (+0.24), RTH: 80.34 (+0.21)

Stocks slightly higher as oil prices reverse decline
By KEN SWEET - AP - Fri Jul 29, 12:02PM CDT
NEW YORK (AP) — Stocks are mostly higher in afternoon trading Friday, as investors worked through another mixed batch of corporate earnings, this time from positive results from Google's parent company Alphabet and Amazon, and disappointing results from oil giants Chevron and Exxon Mobil.
AMZN: 758.81 (+6.20), CVX: 102.48 (+0.69)

Stock Market News for July 29, 2016
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:10AM CDT
Despite decline in energy stocks, benchmarks ended mostly in the green on Thursday on the back of gains in major tech companies.
AMZN: 758.81 (+6.20), F: 12.66 (-0.05), FB: 123.94 (-1.06), XOM: 88.95 (-1.25), HP: 61.97 (+0.82), SLB: 80.52 (+1.47), T: 43.29 (+0.71), LVLT: 50.60 (-0.29), RDS.A: 51.79 (-0.56), MUR: 27.43 (+0.86), GOOGL: 791.34 (+25.50), WMB: 23.97 (+0.89), CVX: 102.48 (+0.69), VZ: 55.41 (+0.55), AAPL: 104.21 (-0.13), APC: 54.53 (+1.17)

Covered Call reports for Marathon Oil Corporation, Amazon.com, Jazz Pharmaceuticals, Kellogg Company and Nike include trade ideas that offer returns of 20% or more!
PR Newswire - Fri Jul 29, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AMZN, JAZZ, K, MRO, and NKE.
AMZN: 758.81 (+6.20), NKE: 55.50 (+0.05), JAZZ: 150.97 (-1.85), MRO: 13.64 (+0.29), K: 82.71 (+0.92)

The Zacks Analyst Blog Highlights: Amazon.com, EVINE Live, Stamps.com and PetMed Express
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:30AM CDT
The Zacks Analyst Blog Highlights: Amazon.com, EVINE Live, Stamps.com and PetMed Express
AMZN: 758.81 (+6.20), PETS: 20.73 (-0.21), STMP: 75.81 (-5.03), EVLV: 1.89 (-0.04)

The Zacks Analyst Blog Highlights: Amazon, Alphabet, CBS, Wynn Resorts and Expedia
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:30AM CDT
The Zacks Analyst Blog Highlights: Amazon, Alphabet, CBS, Wynn Resorts and Expedia
AMZN: 758.81 (+6.20), EXPE: 116.65 (-2.62), WYNN: 97.95 (-6.71), GOOGL: 791.34 (+25.50), CBS: 52.22 (-1.99)

Amazon Beats 2Q Earnings Estimates Courtesy AWS
Sejuti Banerjea - Zacks Investment Research - Fri Jul 29, 5:58AM CDT
Amazon.com's (AMZN) second-quarter EPS of 1.78 was way ahead of the Zacks Consensus Estimate of $1.14.
AMZN: 758.81 (+6.20), PETS: 20.73 (-0.21), STMP: 75.81 (-5.03), GOOGL: 791.34 (+25.50)

How to Trade Amazon's Stock (AMZN) Ahead of Earnings
David Bartosiak - Zacks Investment Research - Thu Jul 28, 5:32PM CDT
David Bartosiak gave us his thought on Amazon (AMZN) before they announced earnings.
AMZN: 758.81 (+6.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...